Introduction: In October 2014, the SGO endorsed genetic testing for all individuals with epithelial
ovarian, fallopian tube, or primary peritoneal cancer (EOC). Limited studies have
shown genetic counseling (GC) referral rates of 20%. Genetic mutations involving 21
genes are thought to explain 24% of EOC. Our objective was to identify rates of GC
referral and the incidence of gene mutations in patients (pts) with EOC at Hartford
Hospital (HH) and The Hospital of Central Connecticut (HOCC).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gynecologic OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2015 Published by Elsevier Inc.
